Imidocarb

• Description:

  Imidocarb is a potent antiprotozoal agent. Imidocarb is active against the parasite B. bovis with an IC50 of 87 μg/mL[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H361-H370

• Target:

  Antibiotic; Parasite

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/imidocarb.html

• Purity:

  98.21

• Solubility:

  DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)

• Smiles:

  O=C(NC1=CC=CC(C2=NCCN2)=C1)NC3=CC=CC(C4=NCCN4)=C3

• Molecular Formula:

  C19H20N6O

• Molecular Weight:

  348.40

• Precautions:

  P260-P264-P270-P280-P330-P405-P501

• References & Citations:

  [1]Rodriguez RI, et al. In vitro responsiveness of Babesia bovis to Imidocarb dipropionate and the selection of a drug-adapted line. Vet Parasitol. 1996 Mar;62 (1-2) :35-41.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [27885-92-3]